Skip to main content
Log in

Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer

  • Published:
Diseases of the Colon & Rectum

Abstract

The profile of serum glycoproteins is altered in malignancy with a relative increase in acute phase reactant proteins. A prospective study has been performed to investigate three sugar moieties (hexose, hexosamine and sialic acid) of these glycoproteins in the serum of large-bowel cancer patients as a possible guide to recurrence, and to compare these three variables with carcinoembryonic antigen (CEA). The three variables indicated the presence of colorectal cancer in over 65 per cent of 107 cancer-bearing subjects. Furthermore, the appearance of metastatic disease was associated with abnormalities in these variables in 10 of 11 patients, and appears more accurately reflected than with CEA. However, the three variables and CEA are cumulative in their value for predicting recurrent cancer. Monitoring of acute phase reactant proteins may therefore be of potential clinical benefit for monitoring of colorectal cancer patients at high risk of recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Evans JS, Vana J, Aronoff BL, Baker HW, Murphy GP. Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg 1978;188:716–20.

    Article  PubMed  CAS  Google Scholar 

  2. Minton JP, James KK, Hurtubise PE, Rinker L, Joyce S, Martin EW Jr. The use of serial carcinoembryonic antigen determinations to predict recurrence of carcinoma of the colon and the time for a second-look operation. Surg Gynecol Obstet 1978;147:208–10.

    PubMed  CAS  Google Scholar 

  3. Beatty JD, Romero C, Brown PW, Lawrence W Jr, Terz JJ. Clinical value of carcinoembryonic antigen: diagnosis, prognosis, and follow-up of patients with cancer. Arch Surg 1979;114:563–7.

    PubMed  CAS  Google Scholar 

  4. Winzler RJ Smyth IM. Studies on the mucoproteins of human plasma. II. Plasma mucoprotein levels in cancer patients. J Clin Invest 1948;27:617–9.

    Article  PubMed  CAS  Google Scholar 

  5. Almquist PO, Lausing E. A study of serum glycoproteins in cancer. Scand J Clin Lab Invest 1957;9:179–89.

    Article  PubMed  CAS  Google Scholar 

  6. Henry RJ, Cannon DC, Winkelman JW. Clinical chemistry: principles and technics. 2nd ed. Hagerstown: Harper & Row, 1974;413:470.

    Google Scholar 

  7. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959;234:1971–5.

    PubMed  CAS  Google Scholar 

  8. Nie NH, Hadlai Hull C, Jenkins JG, et al. Statistical package for the social sciences. 2nd ed. New York: McGraw-Hill 1975:434.

    Google Scholar 

  9. Steward AM, Nixon D, Zamcheck N, Aisenberg A. Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. Cancer 1974;33:1246–52.

    Article  PubMed  CAS  Google Scholar 

  10. Cohen AM, Wood WC. Carcinoembryonic antigen levels as an indicator for reoperation in patients with carcinoma of the colon and rectum. Surg Gynecol Obst 1979;149:22–6.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported by the Rowden White Foundation

About this article

Cite this article

Walker, C., Gray, B.N. & Barnard, R. Serum glycoproteins in diagnosis and monitoring of patients with large-bowel cancer. Dis Colon Rectum 24, 171–175 (1981). https://doi.org/10.1007/BF02962327

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02962327

Key words

Navigation